JP2021526828A5 - - Google Patents

Info

Publication number
JP2021526828A5
JP2021526828A5 JP2020568981A JP2020568981A JP2021526828A5 JP 2021526828 A5 JP2021526828 A5 JP 2021526828A5 JP 2020568981 A JP2020568981 A JP 2020568981A JP 2020568981 A JP2020568981 A JP 2020568981A JP 2021526828 A5 JP2021526828 A5 JP 2021526828A5
Authority
JP
Japan
Prior art keywords
transgenic animal
heavy chain
variable domain
animal according
pseudogene
Prior art date
Application number
JP2020568981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526828A (ja
JP7572861B2 (ja
JPWO2019240998A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/035521 external-priority patent/WO2019240998A1/en
Publication of JP2021526828A publication Critical patent/JP2021526828A/ja
Publication of JP2021526828A5 publication Critical patent/JP2021526828A5/ja
Publication of JPWO2019240998A5 publication Critical patent/JPWO2019240998A5/ja
Priority to JP2024036618A priority Critical patent/JP2024081672A/ja
Application granted granted Critical
Publication of JP7572861B2 publication Critical patent/JP7572861B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020568981A 2018-06-13 2019-06-05 遺伝子変換による自律型重鎖可変ドメインの改変による抗体の産生 Active JP7572861B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024036618A JP2024081672A (ja) 2018-06-13 2024-03-11 遺伝子変換による自律型重鎖可変ドメインの改変による抗体の産生

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862684607P 2018-06-13 2018-06-13
US62/684,607 2018-06-13
PCT/US2019/035521 WO2019240998A1 (en) 2018-06-13 2019-06-05 Production of antibodies by modification of an autonomous heavy chain variable domain by gene conversion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024036618A Division JP2024081672A (ja) 2018-06-13 2024-03-11 遺伝子変換による自律型重鎖可変ドメインの改変による抗体の産生

Publications (4)

Publication Number Publication Date
JP2021526828A JP2021526828A (ja) 2021-10-11
JP2021526828A5 true JP2021526828A5 (https=) 2022-06-09
JPWO2019240998A5 JPWO2019240998A5 (https=) 2022-06-09
JP7572861B2 JP7572861B2 (ja) 2024-10-24

Family

ID=68842067

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020568981A Active JP7572861B2 (ja) 2018-06-13 2019-06-05 遺伝子変換による自律型重鎖可変ドメインの改変による抗体の産生
JP2024036618A Pending JP2024081672A (ja) 2018-06-13 2024-03-11 遺伝子変換による自律型重鎖可変ドメインの改変による抗体の産生

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024036618A Pending JP2024081672A (ja) 2018-06-13 2024-03-11 遺伝子変換による自律型重鎖可変ドメインの改変による抗体の産生

Country Status (7)

Country Link
US (1) US12588664B2 (https=)
EP (1) EP3806630A4 (https=)
JP (2) JP7572861B2 (https=)
KR (1) KR20210021024A (https=)
AU (2) AU2019284252B2 (https=)
CA (1) CA3101859A1 (https=)
WO (1) WO2019240998A1 (https=)

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB2183661B (en) 1985-03-30 1989-06-28 Marc Ballivet Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
DE3600905A1 (de) 1986-01-15 1987-07-16 Ant Nachrichtentech Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4977081A (en) 1987-05-04 1990-12-11 Adi Diagnostics, Inc. Stable rabbit-mouse hybridomas and secretion products thereof
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
WO1990014443A1 (en) 1989-05-16 1990-11-29 Huse William D Co-expression of heteromeric receptors
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
WO1992001043A1 (en) 1990-07-10 1992-01-23 Nkk Corporation Hybridoma which produces avian specific immunoglobulin g
EP1291360A1 (en) 1991-12-13 2003-03-12 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
EP0583980A1 (en) 1992-08-20 1994-02-23 Eli Lilly And Company Method for generating monoclonal antibodies from rabbits
WO1997016537A1 (en) 1995-10-30 1997-05-09 Spectral Diagnostics, Inc. Stable chicken b-cell line and method of use thereof
US5714352A (en) 1996-03-20 1998-02-03 Xenotech Incorporated Directed switch-mediated DNA recombination
EP1644416A4 (en) 2003-06-30 2007-08-29 Centocor Inc ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
SI2311874T1 (sl) 2004-07-22 2017-12-29 Erasmus University Medical Center Rotterdam Department of Cell Biology and Genetics Vezavne molekule
TWI404727B (zh) 2006-01-25 2013-08-11 荷蘭鹿特丹Ｅｒａｓｍｕｓ大學醫學中心 對偶基因排除
JP2010528625A (ja) 2007-06-01 2010-08-26 ビューロウ リサーチ エンタープライザズ リミティド ライアビリティ カンパニー トランスジェニック鳥においてヒトイディオタイプを有する抗体を生産するための組成物及び方法
JP5470817B2 (ja) 2008-03-10 2014-04-16 日産自動車株式会社 電池用電極およびこれを用いた電池、並びにその製造方法
WO2010101802A2 (en) 2009-03-02 2010-09-10 University Of Georgia Research Foundation, Inc. Method to alter sex ratios in avian offspring
GB0905023D0 (en) * 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
US8592644B2 (en) 2009-08-13 2013-11-26 Crystal Bioscience Inc. Transgenic animal for production of antibodies having minimal CDRS
US8754287B2 (en) * 2009-12-10 2014-06-17 Regeneron Pharmaceuticals, Inc. Mice that make heavy chain antibodies
US9394372B2 (en) * 2011-10-21 2016-07-19 Crystal Bioscience Inc. In vivo method for generating diversity in a protein scaffold
JP6136279B2 (ja) 2013-01-15 2017-05-31 株式会社ジェイテクト 転がり軸受装置
US10993420B2 (en) 2013-03-15 2021-05-04 Erasmus University Medical Center Production of heavy chain only antibodies in transgenic mammals
TWI503850B (zh) 2013-03-22 2015-10-11 Polytronics Technology Corp 過電流保護元件
TWI510996B (zh) 2013-10-03 2015-12-01 Acer Inc 控制觸控面板的方法以及使用該方法的可攜式電腦
US20170058029A1 (en) * 2014-05-02 2017-03-02 Chiome Bioscience Inc. Human antibody-producing cell
IL264941B2 (en) 2016-08-24 2025-12-01 Teneobio Inc Transgenic non-human animals producing modified heavy chain-only antibodies
US9816280B1 (en) 2016-11-02 2017-11-14 Matthew Reitnauer Portable floor

Similar Documents

Publication Publication Date Title
DK2509409T3 (en) MICE, WHICH PRODUCES HEAVY CHAIN ANTIBODIES
KR102116296B1 (ko) 일반적인 경쇄 마우스
JP6228589B2 (ja) ｐＨ感受性免疫グロブリン配列を発現する非ヒト動物
CN104302169B (zh) 组氨酸工程改造的轻链抗体和用于生成所述抗体的经基因修饰的非人动物
JP2011182801A5 (https=)
JP2020530760A5 (https=)
US11602136B2 (en) In vivo method for generating diversity in a protein scaffold
AR047372A1 (es) Anticuerpos contra madcam
JP2015519076A5 (https=)
KR102139388B1 (ko) 친화성 성숙 인간 항체의 동정
FI4023059T3 (fi) Ei-ihmiseläimiä, jotka kykenevät DH-DH-uudelleenjärjestymiseen immunoglobuliinin raskasketjun koodaussekvensseissä
Ching et al. Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics
CN116194586A (zh) 一种非人哺乳动物或其子代的制备方法及其应用
US20240206440A1 (en) Animal models and therapeutic molecules
JP2021526828A5 (https=)
JP2021526830A5 (https=)
Yi et al. Analysis of Immunoglobulin organization and complexity in Mink (Neovison vison)
AU2023286840A1 (en) Animal models and therapeutic molecules
JPWO2019240998A5 (https=)
JPWO2019241002A5 (https=)
Martin Generation of Antibodies in Agricultural Species Using Classical and Novel Platforms
RU2021135460A (ru) Мыши с гуманизированной легкой цепью
RU2020116981A (ru) Мыши adam6